Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin

American Journal of Hematology
J C YauJ Holcenberg

Abstract

This is a double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of granulocyte-macrophage colony-stimulating-factor (GM-CSF) after dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP). Fifty-six patients with lymphoma or breast carcinoma were randomized to receive GM-CSF 250 microg/m2 or placebo subcutaneously (SC) every 12 hr after each course of DICEP until recovery of absolute neutrophil count (ANC) of 1.5 x 10(9)/L. Each patient was to receive three courses of DICEP. There were 28 patients in each group. The median duration of ANC below 0.5 x 10(9)/L was 10 versus 12 days for Course 1 (P = 0.010), 10 versus 12 days for Course 2 (P = 0.248), and 16.5 versus 15 days for Course 3 (P = 0.126); platelet counts below 20 x 10(9)/L was 4 versus 4 days for Course 1 (P = 0.586), 8.5 versus 7 days for Course 2 (P = 0.013), and 23.5 versus 10.5 days for Course 3 (P = 0.104); hospitalization for patients readmitted with cytopenic fever were 4 versus 8 days for Course 1 (P = 0.035); 7 versus 6 days for Course 2 (P = 0.692); and 8 versus 12 days for Course 3 (P = 0.884) in the GM-CSF and placebo group, respectively. GM-CSF significantly shortens the duration of neutropenia and readmission only d...Continue Reading

References

Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M Eddy
Oct 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I J DielG Bastert
Sep 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A NeidhartF B Oldham
Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K AntmanL E Schnipper
Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S D HuanF A Holmes
Nov 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R WallersteinM Ewer
Oct 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A NeidhartJ J Rinehart
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NeidhartM Downing
May 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D H JohnsonF A Greco
Aug 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B SleaseR B Epstein
Nov 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P EderL Schnipper
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G SpitzerW McIntyre
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A StahelE Platzer

❮ Previous
Next ❯

Citations

May 22, 2001·Journal of Hematotherapy & Stem Cell Research·K T Godder, P J Henslee-Downey
Jul 17, 2008·Supportive Cancer Therapy·Gary H Lyman, Nicole M Kuderer
Aug 5, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Scott D RamseyGary H Lyman
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Julia BohliusAndreas Engert

❮ Previous
Next ❯

Related Concepts